成人女性における家用大気汚染への曝露は,頸動脈内膜の厚さの増加と関連している:家用大気汚染介入ネットワーク試験の横断的な研究
Lindsay J Underhill1, Lisa de Las Fuentes2, Laura Nicolaou3
1Cardiovascular Division and Global Health Center, Washington University School of Medicine, St. Louis, MO, USA.
International journal of hygiene and environmental health
|September 2, 2025
まとめ
バイオマス燃料による家用大気汚染は 動脈硬化症と関連しています 微細粒子 (PM2. 5) と一酸化炭素 (CO) に高い曝露は,心臓血管疾患のマーカーである頸動脈内膜の厚さの増加と相関しています.
科学分野:
- 環境 健康
- 心血管研究
- 流行病学について
背景:
- 心血管疾患 (CVD) は,特に低・中所得国 (LMICs) で,世界の主要な死因です.
- LMICにおけるバイオマス燃料の使用による家庭用空気汚染 (HAP) は重大な健康問題です.
- HAPは,動脈硬化に伴う炎症と酸化ストレス経路と関連しています.
研究 の 目的:
- HAPの暴露と動脈硬化症との関連を調査する.
- 特定のHAP成分と頸動脈の測定値との関係を評価する.
主な方法:
- HAPIN試験の397人の女性 (40~79歳) の横断分析
- 頸動脈の超音波検査で,内膜の厚さ (CIMT) と動脈硬化性プラークを測定する.
- 粒子状物質 (PM2.5),一酸化炭素 (CO),ブラックカーボン (BC) に対する24時間の個人被曝を評価する.
主要な成果:
- 高いPM2.5とCOの曝露は,平均と最大CIMTの増加と関連していました.
- PM2.5の10μg/m3の上昇は,平均CIMTの0.001mmの上昇と相関している.
- 高いCO被曝四分位は,最も低い四分位と比較してCIMTが著しく高かった.
結論:
- PM2.5とCOへの個人的曝露は,動脈硬化症のバイオマーカーであるCIMTの増加と関連しています.
- HAPと心血管疾患のリスクとの関連を裏付けています.
- HAPに関連したCVDを緩和するための介入に,さらなる研究が役立つかもしれません.
関連する概念動画
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Psychoneuroimmunology: Cardiovascular Disease
77
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
77
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


